Ikarian Capital, LLC Vallon Pharmaceuticals, Inc. Transaction History

Ikarian Capital, LLC

  • $247 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.42 - $2.27 $84,738 - $457,990
-201,758 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$1.79 - $8.0 $6,574 - $29,384
3,673 Added 1.85%
201,758 $380,000
Q3 2021

Nov 15, 2021
BUY
$3.85 - $9.68 $223,627 - $562,262
58,085 Added 41.49%
198,085 $1.44 Million
Q1 2021

May 17, 2021
BUY
$4.32 - $7.83 $604,800 - $1.1 Million
140,000 New
140,000 $649,000

About Vallon Pharmaceuticals, Inc.

VLON Quotes by TradingView
  • Ticker VLON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,512,800
  • Description
  • Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...
More about VLON
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email